Published in Arch Intern Med on August 01, 1978
Cytomegalovirus inclusions in the gastroduodenal mucosa of patients after renal transplantation. Gut (1981) 1.00
The impact of cytomegalovirus infection ≥1 year after primary renal transplantation. Clin Transplant (2010) 0.79
Antimicrobial treatment of pertussis. J Pediatr (1969) 3.77
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol (1994) 3.05
The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest (1995) 2.65
A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework. Science (1988) 2.63
Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation (1999) 2.47
R-B enteric differential system for identification of Enterobacteriaceae. Appl Microbiol (1971) 2.47
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Use of pertussis vaccine in an epidemic involving hospital staff. Lancet (1975) 2.15
The carrier state in pertussis. Am J Epidemiol (1968) 1.86
The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther (1994) 1.82
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation (2000) 1.72
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Pertussis: persistent problems. J Pediatr (1974) 1.69
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis (1982) 1.64
Bordetella parapertussis. Recent experience and a review of the literature. Am J Dis Child (1977) 1.60
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. Chest (1994) 1.48
Characterization of the mouse beta maj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements. Mol Cell Biol (1993) 1.47
Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol (1980) 1.45
Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections. Infect Control Hosp Epidemiol (1992) 1.43
Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by D.N.A. "fingerprinting". Lancet (1978) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Recurrent epidemics caused by a single strain of erythromycin-resistant Staphylococcus aureus. The importance of molecular epidemiology. JAMA (1993) 1.30
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol (1982) 1.28
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Letter: HBAg in breast milk. Lancet (1974) 1.25
Immunosuppression and Merkel cell cancer. Transplant Proc (2002) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Measles vaccine: immunity, reinfection and revaccination. Am J Epidemiol (1973) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat Struct Biol (1996) 1.17
Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers. Ther Drug Monit (1987) 1.17
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc (2005) 1.17
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen. Transplant Proc (2005) 1.15
Acute interstitial nephritis. A clinical and pathologic study based on renal biopsies. Am J Med (1975) 1.14
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant (2007) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Pre-eclampsia with the nephrotic syndrome. Kidney Int (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int (1985) 1.09
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Treatment of Chlamydia trachomatis infections: comparison of 1- and 2-g doses of erythromycin daily for seven days. Sex Transm Dis (1987) 1.08
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med (1986) 1.04
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics (1975) 1.04
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics (1982) 1.03
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. Am J Kidney Dis (1998) 1.03
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02
Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child (1972) 1.02
Screening hospital patients for hepatitis B surface antigen. Am J Clin Pathol (1977) 1.01
Polytetrafluoroethylene graft survival in hemodialysis. JAMA (1983) 1.00
Risk of pneumococcal infections in renal transplant patients. JAMA (1979) 0.98
Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella. Am J Dis Child (1965) 0.98
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis (1985) 0.97
Protection of adults rechallenged with a human rotavirus. J Infect Dis (1990) 0.97
Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol (1996) 0.96
Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. Am J Dis Child (1973) 0.96
Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Am J Dis Child (1975) 0.96
Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child (1969) 0.95
Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis (1998) 0.95
Rubella: studies on the natural disease. The significance of antibody status and communicability among young women. Am J Dis Child (1965) 0.94
Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation (1984) 0.94
Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis (1992) 0.94
Staphylococcus lugdunensis endocarditis after tooth extraction. Clin Infect Dis (1995) 0.94
Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease. J Clin Microbiol (1998) 0.94